Literature DB >> 7387812

Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension.

A J Man in 't Veld, G J Wenting, F Boomsma, R P Verhoeven, M A Schalekamp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387812      PMCID: PMC1429995          DOI: 10.1111/j.1365-2125.1980.tb01079.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

Authors:  D P Henry; B J Starman; D G Johnson; R H Williams
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

Review 2.  Diazoxide.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

3.  Vasodilator administration in the presence of beta-adrenergic blockade.

Authors:  W J Mroczek; W R Lee; M E Davidov; F A Finnerty
Journal:  Circulation       Date:  1976-06       Impact factor: 29.690

Review 4.  Vasodilator drugs in the treatment of hypertension.

Authors:  J Koch-Weser
Journal:  Arch Intern Med       Date:  1974-06

5.  Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

Authors:  R Zacest; E Gilmore; J Koch-Weser
Journal:  N Engl J Med       Date:  1972-03-23       Impact factor: 91.245

6.  Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment.

Authors:  R Sannerstedt; J Stenberg; A Vedin; C Wilhelmsson; L Werkö
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

7.  Effects of autonomic blockade on the baroreflex in man at rest and during exercise.

Authors:  T G Pickering; B Gribbin; E S Petersen; D J Cunningham; P Sleight
Journal:  Circ Res       Date:  1972-02       Impact factor: 17.367

8.  Inhibition of adrenergic function in the treatment of hypertension.

Authors:  E D Frohlich
Journal:  Arch Intern Med       Date:  1974-06

9.  Drug combinations as rational antihypertensive therapy.

Authors:  R W Gifford
Journal:  Arch Intern Med       Date:  1974-06

10.  Studies on the effects of propanolol on plasma catecholamine levels in patients with essential hypertension.

Authors:  K H Rahn; H W Gierlichs; G Planz; R Planz; M Schols; W Stephany
Journal:  Eur J Clin Invest       Date:  1978-06       Impact factor: 4.686

View more
  11 in total

1.  Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

2.  The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects.

Authors:  A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

3.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Topical minoxidil: cardiac effects in bald man.

Authors:  F H Leenen; D L Smith; W P Unger
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

5.  Non-invasive measuring of the circulatory effect of afterload reduction in order to monitor the pharmacodynamic effect of drugs in normal volunteers.

Authors:  J Buch; S Waldorff; P B Hansen; O O Rasmussen
Journal:  Br Heart J       Date:  1983-08

6.  Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

7.  Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.

Authors:  K F Whyte; P J De Vane; R Whitesmith; A Kelman; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

8.  Differential blockade of alpha-adrenoceptors by indoramin.

Authors:  D P Nicholls; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

9.  Diazoxide and labetalol in acute hypertension during haemodialysis.

Authors:  G Keusch; H Schiffl; U Binswanger
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Heart rate control in hypertensive patients treated by captopril.

Authors:  A Sturani; C Chiarini; E Degliesposti; A Santoro; A Zuccalà; P Zucchelli
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.